| GSE67980 | GSM1660182 | AB 5500xl Genetic Analyzer | Homo sapiens | Pr22.1.11 | lineage-confirmed PCa CTC CRPC progressed on enzalutamide (Group B) | donor: Pr22; donor type: CRPC; enzalutamide: progressed on enzalutamide (Group B) |
| GSE70580 | GSM1810685 | Illumina HiSeq 2000 | Homo sapiens | T75_P2_D5_ILC3 | Donor T75-tonsil innate lymphoid cell (ILC3) | tonsil donor: Donor T75; facs gating: ILC3; cell type: tonsil Innate lymphoid cells |
| GSE70580 | GSM1810941 | Illumina HiSeq 2000 | Homo sapiens | T86_P2_A8_ILC2 | Donor T86-tonsil innate lymphoid cell (ILC2) | tonsil donor: Donor T86; facs gating: ILC2; cell type: tonsil Innate lymphoid cells |
| GSE71315 | GSM1832383 | Illumina HiSeq 2500 | Homo sapiens | A1_N704_S506 | Cerebral Cortex GW20.5 | tissue: Cerebral Cortex; developmental stage: GW20.5 |
| GSE71858 | GSM1846954 | Illumina HiSeq 2500 | Homo sapiens | Live_PLRC [US-1457350-15] | cultured embryonic stem cells (H1) DAPI- Live cells FRSCR | cell line: H1; cell type: cultured embryonic stem cells; phenotype: DAPI-; sample group: Live cells_FRSCR |
| GSE72056 | GSM1850755 | Illumina NextSeq 500 | Homo sapiens | Cy81_FNA_CD45_F10_S262_comb | T-cell | tumor-of-origin: Cy81 |
| GSE72056 | GSM1851011 | Illumina NextSeq 500 | Homo sapiens | Cy80_II_CD45_C04_S892_comb | melanoma | tumor-of-origin: Cy80 |
| GSE72056 | GSM1851267 | Illumina NextSeq 500 | Homo sapiens | cy79-p3-CD45-pos-PD1-pos-AS-C2-R1-F09-S453-comb | T-cell | tumor-of-origin: cy79 |
| GSE72056 | GSM1851523 | Illumina NextSeq 500 | Homo sapiens | cy79-p1-CD45-neg-PDL1-pos-AS-C1-R1-C11-S35-comb | melanoma | tumor-of-origin: cy79 |
| GSE72056 | GSM1851779 | Illumina NextSeq 500 | Homo sapiens | cy80-CD45-neg-H05-S953-comb | Endothelial cell | tumor-of-origin: cy80 |
